Updated Jul 30, 2026
/Core Laboratories beats earnings estimate by $0.02, revenue misses at $124.6 million/Ukraine asks Poland to let specialists join field-object investigation/Lane Kiffin's LSU debut carries a $40 million roster and a Playoff mandate/Former Clinton official warns DSA will 'destroy' Democratic Party without leadership pushback/Gumi and SBI launch Bitcoin and altcoin fund as game developer's crypto holdings nearly double/GZPZF declares EUR 4.3-per-share cash dividend, sets December payment date/Core Laboratories beats earnings estimate by $0.02, revenue misses at $124.6 million/Ukraine asks Poland to let specialists join field-object investigation/Lane Kiffin's LSU debut carries a $40 million roster and a Playoff mandate/Former Clinton official warns DSA will 'destroy' Democratic Party without leadership pushback/Gumi and SBI launch Bitcoin and altcoin fund as game developer's crypto holdings nearly double/GZPZF declares EUR 4.3-per-share cash dividend, sets December payment date
NewsSOS
← NewswireMacro

Core Laboratories beats earnings estimate by $0.02, revenue misses at $124.6 million

Non-GAAP earnings per share of $0.11 gave Core Laboratories a $0.02 beat over analyst expectations in its latest period, results showed. Revenue of $124.6 million came in $0.5 million below estimates, the company disclosed.

By Mara Whitfield2 min read
Share

Key takeaways

  • Core Laboratories reported non-GAAP earnings per share of $0.11, beating analyst expectations by $0.02.
  • Revenue came in at $124.6 million, missing estimates by $0.5 million.
  • The non-GAAP figure excludes items such as restructuring charges, stock-based compensation, and other costs designated as outside ordinary operations.
  • The earnings beat points to cost control or favorable treatment of non-operating items, while the revenue shortfall indicates sales came in slightly below forecast.
  • The company did not disclose a further breakdown of the sources behind the revenue gap.

Non-GAAP earnings per share of $0.11 gave Core Laboratories a $0.02 beat over analyst expectations in its latest period, results showed. Revenue of $124.6 million came in $0.5 million below estimates, the company disclosed.

The earnings picture

The $0.11 per-share figure cleared the analyst consensus by $0.02. Non-GAAP results exclude items such as restructuring charges, stock-based compensation, and other costs that companies designate as outside ordinary operations. The beat on that measure means Core Laboratories delivered more per share than analysts had forecast once those exclusions are applied.

Revenue of $124.6 million fell $0.5 million short of estimates. Narrow in absolute terms, that gap still registers as a miss against the number analysts had on the books.

A split result

Core Laboratories delivered opposing signals on its two headline metrics. The $0.02 earnings beat points to cost control or favorable treatment of non-operating items relative to what analysts had modeled. The $0.5 million revenue shortfall indicates sales activity came in slightly below the forecast.

The company disclosed both figures. The reported results did not include a further breakdown of the sources behind the revenue gap.

Related reading

Keep reading

All bulletins →
MacroJuly 30, 2026

Ukraine asks Poland to let specialists join field-object investigation

WARSAW, July 30. Polish prosecutors have received a request from Ukraine to allow Ukrainian specialists to participate in an investigation into an object that recently fell in a field, Polish prosecutorial authorities reported.

2 min read
MacroJuly 30, 2026

Long-term Treasury yields rise after Fed holds rates, Warsh credibility in question

Long-term Treasury yields jumped after the Federal Reserve held interest rates steady, the analysis shows, and investors are now questioning whether Chairman Warsh will act with enough force on inflation. The analysis reports his credibility is in question.

2 min read
MacroJuly 29, 2026

BEA adjustments set to lower Fed's preferred inflation gauge

The Bureau of Economic Analysis is set to implement adjustments to the methodology behind the Federal Reserve's preferred inflation gauge, a change expected to ease pressure on the central bank to raise interest rates.

2 min read

Frequently asked

By how much did Core Laboratories beat earnings estimates?

It beat analyst earnings expectations by $0.02, reporting non-GAAP earnings per share of $0.11.

Did Core Laboratories meet its revenue target?

No, revenue of $124.6 million fell $0.5 million short of analyst estimates, registering as a miss.

What does the non-GAAP earnings figure exclude?

It excludes items such as restructuring charges, stock-based compensation, and other costs the company designates as outside ordinary operations.

Why did revenue fall short of estimates?

The reported results indicate sales activity came in slightly below forecast, but the company did not provide a breakdown of the sources behind the revenue gap.